Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
61,537,276
-
Share change
-
+118,543
-
Total reported value
-
$1,836,566,305
-
Put/Call ratio
-
0%
-
Price per share
-
$29.89
-
Number of holders
-
140
-
Value change
-
-$26,016,240
-
Number of buys
-
63
-
Number of sells
-
58
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2021
As of 30 Sep 2021 ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) had 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,537,276 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., and WESTFIELD CAPITAL MANAGEMENT CO LP.
This table shows 141 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.